Presented by the Warren Alpert Medical School of Brown University, Office of Continuing Medical Education.
This activity is designed for urologists and other healthcare professionals interested in or involved with the management of prostate cancer.
At the conclusion of this activity, participants should be able to:
- Identify patients with castrate-resistant prostate cancer (CRPC) who could benefit from additional treatment
- Review current and future modalities available for the treatment of CRPC
- Discuss therapeutic strategies that may mitigate skeletal-related events (SREs) associated with metastatic prostate cancer and its treatment
Pamela I. Ellsworth, MD, FACS, Program Chair
Associate Professor of Surgery
Division of Urology
The Warren Alpert Medical School of Brown University
Providence, Rhode Island, USA
Christopher P. Evans, MD, FACS
Professor and Chairman
Department of Urology
University of California, Davis School of Medicine
Sacramento, California, USA
Fred Saad, MD, FRCS
Professor and Chairman of Urology
Director of Urologic Oncology
University of Montreal Endowed Chair in Prostate Cancer
University of Montreal Faculty of Medicine
This activity is supported by educational grants from Amgen and Dendreon Corporation.
In accordance with the disclosure policy of the Warren Alpert Medical School of Brown University as well as standards set forth by the Accreditation Council for Continuing Medical Education, all speakers and individuals in a position to control the content of a CME activity are required to disclose relevant financial relationships with commercial interests (within the past 12 months). Disclosures of this activity’s speakers and planning committee have been reviewed and all identified conflicts of interest, if applicable, have been resolved.
Pamela I. Ellsworth, MD, indicates that she is a consultant for Allergan, Inc. and Pfizer Inc; a speaker for Pfizer Inc; has participated in speaker training for Novartis Pharmaceuticals Corporation; and has participated in clinical research studies sponsored by Novartis Pharmaceuticals Corporation and Pfizer Inc.
Christopher P. Evans, MD, FACS, indicates that he does not have any relevant financial relationships.
Fred Saad, MD, FRCS, indicates that he has received grant/research support from and has served as a consultant for Amgen and Novartis Pharmaceuticals Corporation.
Activity planners from the Alpert Medical School Office of Continuing Medical Education, Health and Wellness Education Partners, and UroToday have reported that they have no relevant financial relationships with commercial interests.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Warren Alpert Medical School of Brown University, and Health and Wellness Education Partners. The Alpert Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The Alpert Medical School designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.5 hours of Category 1 credit for completing this program.
Program Release: June 1, 2011
Program Expiration: June 30, 2012
Estimated time to complete: 90 minutes
There are no prerequisites for participation.
Method of Participation and How To Receive CME Credit
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives, faculty information, and CME information prior to participating in the activity.
- Complete the CME activity.
- For receipt of CME credit, complete the CME posttest and activity evaluation at the conclusion of the activity.
- A minimum score of 70% is required to receive a CME credit certificate.
- Your CME credit certificate will be emailed to you within four weeks of activity completion.
- To complete the posttest and evaluation for this activity and receive CME credit, click here.
The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants and educational collaborators. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. CME collects only the information necessary to provide you with the services that you request.
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. The use of the Warren Alpert Medical School of Brown University name implies review of educational format, design, and approach. Activity participants have the professional responsibility to review the complete prescribing information of specific drugs or combination of drugs including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients. The Warren Alpert Medical School assumes no liability for the information herein.
To Receive CME Credit
To complete the posttest and evaluation for this activity and receive CME credit, click here.